Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes

被引:108
作者
Christiansen, Elisabeth [1 ]
Urban, Christian [2 ]
Merten, Nicole [3 ]
Liebscher, Kathrin [4 ]
Karlsen, Kasper K. [1 ]
Hamacher, Alexandra [2 ]
Spinrath, Andreas [3 ]
Bond, Andrew D. [1 ]
Drewke, Christel [3 ]
Ullrich, Susanne [4 ]
Kassack, Matthias U. [2 ]
Kostenis, Evi [3 ]
Ulven, Trond [1 ]
机构
[1] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark
[2] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany
[3] Univ Bonn, Inst Pharmaceut Biol, Dept Mol Cellular & Pharmacobiol, D-53115 Bonn, Germany
[4] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-72076 Tubingen, Germany
基金
英国医学研究理事会;
关键词
D O I
10.1021/jm8010178
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 4-phenethynyldihydrocinnamic acid agonists of the free fatty acid receptor 1 (FFA(1)) has been discovered and explored. The preferred compound 20 (TUG-424, EC50 = 32 nM) significantly increased glucose-stimulated insulin secretion at 100 nM and may serve to explore the role of FFA(1) in metabolic diseases such as diabetes or obesity.
引用
收藏
页码:7061 / 7064
页数:4
相关论文
共 25 条
[21]   Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice [J].
Tan, Carina P. ;
Feng, Yue ;
Zhou, Yun-Ping ;
Eiermann, George J. ;
Petrov, Aleksandr ;
Zhou, Changyou ;
Lin, Songnian ;
Salituro, Gino ;
Meinke, Peter ;
Mosley, Ralph ;
Akiyama, Taro E. ;
Einstein, Monica ;
Kumar, Sanjeev ;
Berger, Joel P. ;
Mills, Sander G. ;
Thornberry, Nancy A. ;
Yang, Lihu ;
Howard, Andrew D. .
DIABETES, 2008, 57 (08) :2211-2219
[22]   Discovery of novel Agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening [J].
Tikhonova, Irina G. ;
Sum, Chi Shing ;
Neumann, Susanne ;
Engel, Stanislav ;
Raaka, Bruce M. ;
Costanzi, Stefano ;
Gershengorn, Marvin C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :625-633
[23]   Bidirectional, iterative approach to the structural delineation of the functional "Chemoprint" in GPR40 for agonist recognition [J].
Tikhonova, Irina G. ;
Sum, Chi Shing ;
Neumann, Susanne ;
Thomas, Craig J. ;
Raaka, Bruce M. ;
Costanzi, Stefano ;
Gershengorn, Marvin C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (13) :2981-2989
[24]   Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion [J].
Ullrich, S ;
Berchtold, S ;
Ranta, F ;
Seebohm, G ;
Henke, G ;
Lupescu, A ;
Mack, AF ;
Chao, CM ;
Su, JP ;
Nitschke, R ;
Alexander, D ;
Friedrich, B ;
Wulff, P ;
Kuhl, D ;
Lang, F .
DIABETES, 2005, 54 (04) :1090-1099
[25]   Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization [J].
Vettor, Roberto ;
Granzotto, Marnie ;
De Stefani, Diego ;
Trevellin, Elisabetta ;
Rossato, Marco ;
Farina, Maria Grazia ;
Milan, Gabriella ;
Pilon, Catia ;
Nigro, Angela ;
Federspil, Giovanni ;
Vigneri, Riccardo ;
Vitiello, Libero ;
Rizzuto, Rosario ;
Baratta, Roberto ;
Frittitta, Lucia .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) :3541-3550